Publication: Patritumab deruxtecan (HER3-DXd) in early-stage HR+/HER2-breast cancer: Final results of the SOLTI TOT-HER3 window of opportunity trial
No Thumbnail Available
Identifiers
Date
2022-05-05
Authors
Prat, A.
Falato, C.
Pare Brunet, L.
Martinez Saez, O.
Cejalvo Andujar, J. M.
Margeli Vila, M.
Tolosa, P.
Salvador Bofill, F. J.
Cruz Jurado, J.
Gonzalez-Farre, B.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
